NITROFURANTOIN SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for nitrofurantoin sodium and what is the scope of patent protection?
Nitrofurantoin sodium
is the generic ingredient in one branded drug marketed by Procter And Gamble and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for NITROFURANTOIN SODIUM
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Clinical Trials: | 1 |
DailyMed Link: | NITROFURANTOIN SODIUM at DailyMed |
Recent Clinical Trials for NITROFURANTOIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alphacait, LLC | Phase 2 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for NITROFURANTOIN SODIUM
US Patents and Regulatory Information for NITROFURANTOIN SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Procter And Gamble | IVADANTIN | nitrofurantoin sodium | INJECTABLE;INJECTION | 012402-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |